ONCY
Oncolytics Biotech
ONCY
ONCY
46 hedge funds and large institutions have $1.21M invested in Oncolytics Biotech in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.15% more ownership
Funds ownership: 1.55% → 1.71% (+0.15%)
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$90K | |
| 2 | +$39.8K | |
| 3 | +$24.2K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.8K |
| 5 |
Goldman Sachs
New York
|
+$15K |
Top Sellers
| 1 | -$69K | |
| 2 | -$34.8K | |
| 3 | -$12.3K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.89K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$5.93K |